Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Bioquell’s Vapor Producing Robots Selected to Combat Ebola in Hospitals Around the World
  • USA - English


News provided by

720 Strategies

Oct 17, 2014, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Horsham, PA (PRWEB) October 17, 2014 -- Bioquell, provider of germ-eliminating robots and services, is being called upon by health facilities around the world to decontaminate locations where Ebola-infected and exposed patients are being treated. Among the many places the hydrogen peroxide vapor technology is being used includes Texas Health Presbyterian Hospital Dallas and at the National Institutes of Health (NIH) Clinical Center. The state-of-the-art vapor-producing robots have been utilized to decontaminate patient rooms, equipment, and an ambulance at NIH.

The effectiveness of the technology – designed and produced by Bioquell – has been recognized by hospitals and government agencies around the world. Since the beginning of the recent Ebola outbreak, Bioquell’s robots and decontamination teams have been deployed globally to treat hospital rooms at risk of contamination with Ebola, including the United States, United Kingdom, France and Holland.

The portable, automated system uses a 35 percent hydrogen peroxide solution, which is distributed as a vapor throughout the contaminated area, ensuring complete, three-dimensional coverage. After the EPA-registered hydrogen peroxide is removed and the decontamination effectiveness is verified, emergency vehicles and hospital rooms can return to service immediately.

“With a pathogen such as Ebola, totally eliminating any risk of residual contamination is clearly of paramount importance,” James Salkeld, Head of Healthcare at Bioquell said. “It is reassuring to see that the NIH and hospitals globally are adopting a zero tolerance policy by selecting Bioquell’s technology to decontaminate risk areas.”

For more information or to request an interview contact:
Doug Simon
press(at)720strategies(dot)com
(202) 962-3955

Read more about Bioquell’s work eliminating Ebola around the globe:

Investors recognize work Bioquell is doing to decontaminate Ebola: http://www.telegraph.co.uk/finance/markets/marketreport/11152714/Market-report-Ebola-worries-draw-attention-to-Bioquell.html

Bioquell used to eliminate Ebola at High Level Isolation Unit at the Royal Free Hospital: http://www.bioquell.com/en-uk/about/media-centre/latest-news/all-categories/vapour-producing-robots-used-against-ebola/

Hospital rooms decontaminated at Holland’s Leiden University Medical Center: http://www.bioquell.com/en-uk/about/media-centre/latest-news/healthcare/vapour-producing-robots-used-against-ebola-netherlands/

Bioquell decontaminates ambulance, television equipment in France: http://www.bioquell.com/en-uk/about/media-centre/latest-news/healthcare/bioquell-france-ebola-decontamination-interventions/

About Bioquell

Bioquell specializes in the design, manufacture and application of complete bio-decontamination solutions for airborne and surface contamination in the healthcare, life sciences, food production and defense sectors. Bioquell's unique hydrogen peroxide vapor bio-decontamination technology has been used across the globe to eradicate problematic bacteria, viruses and fungi, throughout a wide range of applications. Services have been deployed across the globe and range from proactive to emergency based situations. For more information, please visit http://www.bioquell.com.

For more information regarding the technology, environmental decontamination, or Ebola infection control efforts, please contact Bioquell at healthcare(at)bioquell(dot)com or by calling 215-682-0225.

Frequently Asked Questions about Bioquell and Ebola:

Once an Ebola patient has left a facility, is there still a risk of exposure?
Yes, because the disease is transmitted through bodily fluids, any fluids that remain in the room could create a continued risk of exposure. We know that hospitals often carry the largest risk of spreading infectious diseases. It is important for hospitals and other treatment facilities to take the strongest precautions in decontaminating any area or equipment that is exposed to the Ebola virus.

How is the Ebola virus eliminated from a facility after the patient has left? Bioquell uses a state-of-the-art technology to fully decontaminate the facility once the patient's treatment is completed or they are moved to another location. This technology doesn't damage any of the equipment used in the facility, and it doesn't require exposing any hospital staff to the contaminated facility. Instead, the Bioquell robot is moved into the room and emits a hydrogen peroxide vapor. This vapor enters every nook and cranny of the room and completes disinfection. It's also safe for use with electronic devices.

How can someone be sure the virus has been eliminated?
Bioquell uses a verification system that allows us to ensure that contaminants have been eliminated. We place biological and chemical test strip indicators on the walls and other locations in the facility to ensure complete exposure to the hydrogen peroxide solution.

What’s different about Bioquell than other disinfectants on the market like those that emit UV lights?
Bioquell is the leading product for elimination of superbugs in hospital facilities. There are many products on the market that work in other situations. For example, products that emit UV lights are beneficial for hospitals trying to reduce the presence of disease, but they are not effective at total elimination. Machines that emit UV lights are limited by shadowing and decreased effectiveness at longer distances, creating varied results. Bioquell distributes a vapor that can reach inside every exposed nook and cranny of a hospital room or other facility. Bioquell’s vapor cycles are repeatable and achieve the highest level of disinfection every time.

Is this a new technology?
No, the Bioquell system has been used to eliminate other "super bugs" from hospitals and treatment facilities. Many hospitals depend on Bioquell to ensure that bugs like MRSA (common antibiotic-resistant bacteria) are eliminated from hospital rooms. Our robots are used around the globe to create safer hospitals.

What if there is a large-scale outbreak of Ebola outside of West Africa?
Bioquell has a large technician team, as well as a large inventory of robots. This allows us to quickly handle high demand and scale up for large area decontamination, if necessary. Any area that can be isolated has the ability to be decontaminated. Bioquell also has a complimentary technology – the Pod (http://www.bioquell.com/en-uk/markets/product-selector/bioquell-pod/), which can take a large, open area and segment it into single room enclosures. This technology - recently implemented in the Middle East and the UK where open hospital units are common – are designed to limit the spread of pathogens in open units (many ER’s in the US are still open).

How dangerous are hospital or treatment facilities left untreated after an Ebola patient leaves?
Ebola can survive on dry surfaces for days and even weeks under certain conditions, especially when dried in blood or other body fluids. This may be a risk for incoming patients if not decontaminated adequately.

Why is your technology the most effective?
The Bioquell technology is validated by many years of research from institutions like Johns Hopkins Hospital and Yale University. Because the technology delivers an equal distribution of vapor throughout the room or ambulance, it is the most effective in ensuring all areas have been decontaminated. Bioquell uses special chemical and biological indicators to validate or verify that the decontamination has been achieved. The process kills 99.9999% of pathogens on surfaces, which is associated with elimination, not just reduction.

Manual cleaning relies on hospital staff. Special attention is needed to ensure the appropriate distribution of the cleaning agent is applied and the contact and dwell time meet the label directions to be effective. Even with that, it is difficult for a human to touch every surface evenly. Other no-touch decontamination technologies are associated with a reduction, but not an elimination of organisms. This is typically due to issues with distribution, like line of sight and shadowing, combined with less killing power.

Hydrogen peroxide seems like such a simple chemical, how does it work to eliminate Ebola, which seems like such a super bug?
Bioquell utilizes a 35 percent hydrogen peroxide solution, which is an EPA-registered sterilant. The robot vaporizes hydrogen peroxide and it is then distributed evenly throughout the room. When the invisible, residue-free vapor comes in contact with the bug, the bug is killed. The technology is the driving force behind the results since it allows the hydrogen peroxide to be distributed evenly and in a repeatable manner.

Doug Simon, 720 Strategies, +1 (202) 715-3909, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.